1. Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
- Author
-
Desch, Steffen, Zeymer, Uwe, Akin, Ibrahim, Behnes, Michael, Duerschmied, Daniel, Rassaf, Tienush, Mahabadi, Amir Abbas, Lehmann, Ralf, Eitel, Ingo, Graf, Tobias, Seidler, Tim, Schuster, Andreas, Thevathasan, Tharusan, Skurk, Carsten, Clemmensen, Peter, Hennersdorf, Marcus, Fichtlscherer, Stephan, Voigt, Ingo, Seyfarth, Melchior, and John, Stefan
- Subjects
MYOCARDIAL infarction ,MEDICAL personnel ,CARDIOGENIC shock ,PATIENT selection ,MEDICAL care ,EXTRACORPOREAL membrane oxygenation ,INTRA-aortic balloon counterpulsation - Abstract
The ECLS-SHOCK trial, published in the European Heart Journal, investigated the use of extracorporeal life support (ECLS) in patients with cardiogenic shock (CS) related to acute myocardial infarction (AMI). The trial found that routine ECLS did not improve 1-year survival compared to standard medical care alone. The study also revealed no significant differences in secondary endpoints such as neurological outcome, myocardial reinfarction, repeat revascularization, or rehospitalization for heart failure between the two groups. The trial highlights the need for further research on the role of ECLS in the management of AMI-CS. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF